W Hiddemann

[Clinical studies: an endangered element in optimizing treatment].

W Hiddemann, 2002, Deutsche medizinische Wochenschrift.

Flow cytometric characterization of acute myeloid leukemia. Part II. Phenotypic heterogeneity at diagnosis.

W Hiddemann, M R Loken, W. Hiddemann, 1992, Leukemia.

Weekly docetaxel (Taxotere) in patients with metastatic breast cancer.

H Sommer, W Hiddemann, W. Hiddemann, 2001, Annals of oncology : official journal of the European Society for Medical Oncology.

Neoadjuvant chemotherapy combined with regional hyperthermia (RHT) for locally advanced primary or recurrent high-risk adult soft-tissue sarcomas (STS) of adults: long-term results of a phase II study.

W Hiddemann, U. Aydemir, W. Hiddemann, 2001, European journal of cancer.

Pediatric acute lymphoblastic leukemia (ALL) gene expression signatures classify an independent cohort of adult ALL patients

W Hiddemann, M Dugas, A Kohlmann, 2004, Leukemia.

Lymphoma classification--the gap between biology and clinical management is closing.

W Hiddemann, J. Armitage, F. Cavalli, 1996, Blood.

Age, not therapy intensity, determines outcomes of adults with acute myeloid leukemia

C Haferlach, W Hiddemann, T Haferlach, 2016, Leukemia.

Prednimustine, mitoxantrone (PmM) vs cyclophosphamide, vincristine, prednisone (COP) for the treatment of advanced low-grade non-Hodgkin's lymphoma. German Low-Grade Lymphoma Study Group.

W Hiddemann, A Engert, M. Tiemann, 1996, Leukemia.

Genetic classification of acute myeloid leukemia (AML).

W Hiddemann, T Haferlach, W. Hiddemann, 2004, Annals of hematology.